Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CSPC Pharmaceutical Group ( (HK:1093) ) just unveiled an update.
CSPC Pharmaceutical Group has announced an interim dividend of HKD 0.14 per share for the six months ending June 30, 2025. This decision reflects the company’s ongoing commitment to delivering shareholder value and may enhance its attractiveness to investors, potentially strengthening its market position.
The most recent analyst rating on (HK:1093) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group is a prominent player in the pharmaceutical industry, primarily engaged in the development, manufacturing, and sale of pharmaceutical products. The company focuses on innovative drug research and development, generic drug production, and healthcare services, catering to both domestic and international markets.
Average Trading Volume: 214,665,843
Technical Sentiment Signal: Buy
Current Market Cap: HK$122.4B
See more data about 1093 stock on TipRanks’ Stock Analysis page.